Showing results (1151-1160 of 1,203) with videos related to

Sort By:
Pageof 121
Annals of the Rheumatic Diseases|August 30, 2005
A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune diseaseH Tsukamoto, K Nagafuji, T Horiuchi, et al.
British Journal of Haematology|June 1, 1997
Common clonal origin of lymphocytes and plasma cells in splenic lymphoma with villous lymphocytesY Katayama, K Kojima, T Yoshino, et al.
Scientific Reports|December 10, 2025
Effect of assisted hatching on pregnancy outcomes following 1,678,872 single embryo transfers based on the Japan Assisted Reproductive Technology RegistryA Kusamoto, M Harada, T Kawahara, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2001
Ghrelin strongly stimulates growth hormone release in humansK Takaya, H Ariyasu, N Kanamoto, et al.
Cell Death and Differentiation|March 18, 2014
Disruption of the temporally regulated cloaca endodermal β-catenin signaling causes anorectal malformationsS Miyagawa, M Harada, D Matsumaru, et al.
JAMA Internal Medicine|August 14, 2023
Association of Intensive Lifestyle Intervention for Type 2 Diabetes With Labor Market OutcomesPeter J Huckfeldt, Jeffrey C Yu, Paul K O'Leary, et al.
Bone Marrow Transplantation|December 3, 2003
Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignanciesS Yamasaki, Y Ohno, S Taniguchi, et al.
Bone Marrow Transplantation|September 7, 2010
Role of autotransplantation in the treatment of acute promyelocytic leukemia patients in remission: Fukuoka BMT Group observations and a literature reviewT Kamimura, T Miyamoto, K Nagafuji, et al.
Bone Marrow Transplantation|August 26, 1998
Allogeneic peripheral blood stem cell transplantation for standard-risk leukemia. A multicenter pilot study: Japanese experience. Japan Blood Cell Transplantation Study GroupM Harada, K Shinagawa, T Kawano, et al.
Oncogene|May 3, 2006
Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumorsT Yoshida, T Hisamoto, J Akiba, et al.
Pageof 121